121 related articles for article (PubMed ID: 29875896)
1. Cost of shifting from healthcare to long-term care in later life across major diseases: analysis of end-of-life care during the last 24 months of life.
Terada T; Nakamura K; Seino K; Kizuki M; Inase N
J Rural Med; 2018 May; 13(1):40-47. PubMed ID: 29875896
[No Abstract] [Full Text] [Related]
2. Economic Burden of Alzheimer's Disease Dementia in Japan.
Ikeda S; Mimura M; Ikeda M; Wada-Isoe K; Azuma M; Inoue S; Tomita K
J Alzheimers Dis; 2021; 81(1):309-319. PubMed ID: 33780371
[TBL] [Abstract][Full Text] [Related]
3. Care pathways at end-of-life for cancer decedents: registry based analyses of the living situation, healthcare utilization and costs for all cancer decedents in Norway in 2009-2013 during their last 6 months of life.
Bjørnelv G; Hagen TP; Forma L; Aas E
BMC Health Serv Res; 2022 Oct; 22(1):1221. PubMed ID: 36183057
[TBL] [Abstract][Full Text] [Related]
4. [Healthcare expenditure and the impact of age: a detailed analysis for survivors and decedents].
Stahmeyer JT; Hamp S; Zeidler J; Eberhard S
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 Oct; 64(10):1307-1314. PubMed ID: 34258630
[TBL] [Abstract][Full Text] [Related]
5. Social burden of three major diseases in Japan: A time trend and future projections using the comprehensive cost of illness method.
Hirata K; Matsumoto K; Hatakeyama Y; Onishi R; Seto K; Hasegawa T
PLoS One; 2023; 18(1):e0280311. PubMed ID: 36630469
[TBL] [Abstract][Full Text] [Related]
6. Community-based specialist palliative care is associated with reduced hospital costs for people with non-cancer conditions during the last year of life.
Spilsbury K; Rosenwax L
BMC Palliat Care; 2017 Dec; 16(1):68. PubMed ID: 29216873
[TBL] [Abstract][Full Text] [Related]
7. Hospital Expenditure at the End-of-Life: A Time-to-Death Approach.
Alipour V; Pourreza A; Kosheshi M; Heydari H; Emamgholipour Sefiddashti S
Int J Health Policy Manag; 2022 Feb; 11(2):138-144. PubMed ID: 32610810
[TBL] [Abstract][Full Text] [Related]
8. Dying with Parkinson's Disease: Healthcare Utilization and Costs in the Last Year of Life.
Zwicker J; Qureshi D; Talarico R; Webber C; Watt C; Kim W; Milani C; Ramanathan U; Mestre T; Tanuseputro P
J Parkinsons Dis; 2022; 12(7):2249-2259. PubMed ID: 36120791
[TBL] [Abstract][Full Text] [Related]
9. Does Last Year's Cost Predict the Present Cost? An Application of Machine Leaning for the Japanese Area-Basis Public Health Insurance Database.
Nomura Y; Ishii Y; Chiba Y; Suzuki S; Suzuki A; Suzuki S; Morita K; Tanabe J; Yamakawa K; Ishiwata Y; Ishikawa M; Sogabe K; Kakuta E; Okada A; Otsuka R; Hanada N
Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33445431
[TBL] [Abstract][Full Text] [Related]
10. The estimated cost of dementia in Japan, the most aged society in the world.
Sado M; Ninomiya A; Shikimoto R; Ikeda B; Baba T; Yoshimura K; Mimura M
PLoS One; 2018; 13(11):e0206508. PubMed ID: 30418983
[TBL] [Abstract][Full Text] [Related]
11. Escalating Health Care Expenditures in Cancer Decedents' Last Year of Life: A Decade of Evidence from a Retrospective Population-Based Cohort Study in Taiwan.
Hung YN; Liu TW; Wen FH; Chou WC; Tang ST
Oncologist; 2017 Apr; 22(4):460-469. PubMed ID: 28232596
[TBL] [Abstract][Full Text] [Related]
12. Relationship between use of general practice and healthcare costs at the end of life: a data linkage study in New South Wales, Australia.
Tran B; Falster MO; Girosi F; Jorm L
BMJ Open; 2016 Jan; 6(1):e009410. PubMed ID: 26743704
[TBL] [Abstract][Full Text] [Related]
13. Healthcare Costs Among Patients with Heart Failure: A Comparison of Costs between Matched Decedent and Survivor Cohorts.
Obi EN; Swindle JP; Turner SJ; Russo PA; Altan A
Adv Ther; 2017 Jan; 34(1):261-276. PubMed ID: 27933568
[TBL] [Abstract][Full Text] [Related]
14. Health Care Utilization and Costs for Patients With End-Stage Liver Disease Are Significantly Higher at the End of Life Compared to Those of Other Decedents.
Kelly EM; James PD; Murthy S; Antonova L; Wong F; Shaw-Stiffel T; Chalifoux M; Salim M; Tanuseputro P
Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2339-2346.e1. PubMed ID: 30743007
[TBL] [Abstract][Full Text] [Related]
15. Predicting the Societal Value of Lecanemab in Early Alzheimer's Disease in Japan: A Patient-Level Simulation.
Igarashi A; Azuma MK; Zhang Q; Ye W; Sardesai A; Folse H; Chavan A; Tomita K; Tahami Monfared AA
Neurol Ther; 2023 Aug; 12(4):1133-1157. PubMed ID: 37188886
[TBL] [Abstract][Full Text] [Related]
16. Cost analysis of leuprorelin acetate in Japanese pre-menopausal breast-cancer patients: comparison between 6-month and 3-month depot formulations.
Goto R; Uda A; Hiroi S; Iwasaki K; Takashima K; Kurebayashi J
J Med Econ; 2017 Nov; 20(11):1163-1169. PubMed ID: 28782387
[TBL] [Abstract][Full Text] [Related]
17. Trajectories of end-of-life medical and long-term care expenditures for older adults in Japan: retrospective longitudinal study using a large-scale linked database of medical and long-term care claims.
Teraoka E; Kunisawa S; Imanaka Y
BMC Geriatr; 2021 Jun; 21(1):403. PubMed ID: 34193081
[TBL] [Abstract][Full Text] [Related]
18. Relating cause of death with place of care and healthcare costs in the last year of life for patients who died from cancer, chronic obstructive pulmonary disease, heart failure and dementia: A descriptive study using registry data.
van der Plas AG; Oosterveld-Vlug MG; Pasman HR; Onwuteaka-Philipsen BD
Palliat Med; 2017 Apr; 31(4):338-345. PubMed ID: 28056634
[TBL] [Abstract][Full Text] [Related]
19. National health insurance expenditure for adult beneficiaries in Taiwan in their last year of life.
Liu CN; Yang MC
J Formos Med Assoc; 2002 Aug; 101(8):552-9. PubMed ID: 12440085
[TBL] [Abstract][Full Text] [Related]
20. Health care expenditure in the last five years of life is driven by morbidity, not age: A national study of spending trajectories in Danish decedents over age 65.
Hansen AV; Mortensen LH; Trompet S; Westendorp R
PLoS One; 2020; 15(12):e0244061. PubMed ID: 33338069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
